ArticleFrontiers in pharmacology2021

Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19.

Nina V Vorobjeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.